Reducing exposure to medicines is always a good thing if similar clinical outcomes can be achieved, and the study suggests it ...

That’s it for 2025’s Q1 clinical trials round-up. If you have a study that could fit the bill for our next column, please ...

Bayer chief executive Bill Anderson has said that newer product launches have offset the decline in sales of anticoagulant ...

The progress made in liver disease research to date presents an opportunity for further advancements in the near future.

Just a few months after announcing a plan to separate its drug and cell therapy businesses into two separate companies, ...

Improving Global Access to Life-Changing Therapeutics... Following the successful Boston and London meetings, the ...

Netherlands biotech Azafaros is poised to start phase 3 trials of its lead drug for a trio of rare lysosomal storage ...

That is according to the chief executive of the American Association for the Advancement of Science (AAAS), Sudip Parikh, who ...

In the REAL8 basket trial, Sogroya (somapacitan), administered as a once-weekly subcutaneous injection, was at least as ...

The metabolic effects of weight management medicines extend beyond appetite regulation. Still, with more questions about ...

The UK exported £127 million in medicinal and pharmaceutical products to India in 2024, according to the organisation's ...

Tom Keith-Roach, president of AZ's UK business, said: "The UK approval of Trixeo Aerosphere with the [new] propellant marks a ...